chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first shot I only had arm soreness for about a week, I got the second shot at 8am and the next afternoon at 2pm I had a temperature of 101, chills, and body aches. I felt like a truck had hit me, and by 10pm I was fine. I had the 1st shot on 01/16/2021 and before 01/30/2021 I had a very red itchy patch about the size of a dime on my right foot and as the months have gone its progressed to 2in long by 1in and a half wide. The skin was itchy, bumpy, red, very irritated even when I got in the shower. I went on 02/02/2021 to one doctor he said it was just a rash and it will go away. Then I went to another doctor on 04/06/2021 and she gave me 1% of hydrocortisone to make it quit itching and by that time it was probably and 1 long and 1 in wide and it was itching and hurting. Then I called my dermatologist on 06/01/2021 and she gave me oral medication. She did a swab on it and it came back negative. Now I can take a shower without it hurting so bad.
rash & itching @ inj site;skin lesions to rt cheek trunk & inner thigh;nausea;no vomiting;no temp;all lesions dried & crusted by 8DEC97;
She developed soreness at injection site within one hour of PREVNAR administration. This continued until Sunday, 11/12/17, when she developed redness and warmth at site as well. She took one Benadryl 25 mg last night. Pain is a little better. In office today, 11/15/17,  she has an area on her anterior right arm below her right deltoid that is slightly raised, red and warm to touch. Area extends 12 inches down her arm to her elbow and across her arm 5 inches. She has no fever today. No lymphadenopathy. No other symptoms. Treated today with Benadryl 25 mg q 6 hours prn and Keflex 500 mg po BID X 7 days.
Rash on legs and forearms. Prescribed prescription topical cream and other non-prescription allergy meds. Rash has not subsided as of second day of treatment.
pt recv vax & immed sl stiffening all extremities BP 118/84, P66 regular, s/s lasted 5 seconds;immed rxn to TD was gen tonic/clonic sz w/20 sec loss of consciousness;reported spots before eyes;BP 102/83 & 140/84;weak & clammy;
This spontaneous report was received from a physician and refers to an unknown number of patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ orally (lot # L039638, expiration date: 23-AUG-2017; dose not provided). The vaccine underwent a temperature excursion of 29.7 degrees Fahrenheit for 21 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Started the morning after second shot with feeling cold and nauseous, then it turned into a fever of 100.9 and chills, a headache, dizziness, and still nauseous. Fever broke sometime between 4:00 p.m. and 8;00, while I was asleep. Two 200mg tablets of ibuprofen were taken around 2:00 p.m. and again at 9:00 p.m. that evening for headache. A mild headache and nausea last until approximately noon the next day. A general state of lethargy lasted until the evening of that day, afterwards there were no symptoms
Pt recvd 2 doses of Engerix-B & about 1 wk following dose 2 JUN92 exp rash, fever & malaise;
dead arm; tired and sleepy for about 4-5 days; tired and sleepy for about 4-5 days; The first shot gave me severe itching on the third day; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 46-year-old female patient received BNT162b2 (BNT162B2), on 21Dec2020 at 17:00 as dose 1, single (Lot number: EJ1685) at the age of 45 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "Asthma", start date: Oct1997 (ongoing); "Migraine", start date: 2000 (ongoing). Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL SULFATE] taken for asthma (ongoing); RIZATRIPTAN oral taken for migraine (ongoing). The following information was reported: PRURITUS (non-serious) with onset 24Dec2020, outcome "unknown", described as "The first shot gave me severe itching on the third day"; LIMB DISCOMFORT (non-serious), outcome "recovered", described as "dead arm"; SOMNOLENCE (non-serious), FATIGUE (non-serious), outcome "recovered" and all described as "tired and sleepy for about 4-5 days". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received second dose of BNT162b2 (Lot Number: EL1283) on 10Jan2021 at 07:00 in left deltoid. No other vaccinations were given within four weeks prior to the first administration date of the suspect vaccine. It was reported that the second shit almost killed her. She Experienced a blinding headache within the hour of administration. It was so severe she had to leave work. Headache was so bad she passed out at home. Had vomiting and diarrhea for 7 day straight, fever 6 days. she had developed a third boost under her arm pit. The headache is everyday all day, depending on how hectic her day that's how big her headache will be. she had terrible allergies joint pain and a nose drip with clear discharge that will not cease.
Patient says that a couple of days after receiving her vaccine, her arm became red and swollen and hot to the touch on the upper part of her arm (elbow to shoulder) where she had received the injection. She went to see her doctor who told her that he also had 2 other patients come in who had received their COVID vaccines around the same time as the patient did who had the same symptoms (they received their vaccines from other clinics - not our pharmacy). Patient does not currently have any symptoms. Treatment is unknown.
This spontaneous report as received from a registered nurse refers to a 30 year old female patient. None pertinent medical history, concomitant medications and drug reactions/allergies were reported. On unknown dates (reported as as a child), the patient was vaccinated with the first and the second dose of M-M-R II (dose, route, lot # and expiration date were not reported). The patient was unable to obtain her immunization record, so titers were drawn on 08-JUL-2016, and it showed that the patient was negative for immunity to mumps. As a result, the patient was administered the third dose of M-M-R II (lot L049314, albumin status rHA; dose, route and expiration date were not reported) on 21-JUL-2016. Titers have not been rechecked at the time of this report. It was also provided that the patient received an unspecified treatment of the adverse event. The outcome of the adverse event was unknown. The relatedness between the adverse event and M-M-R II was not provided. Additional information has been requested.
I went two times; I think on Tuesday. On October 29th and Nov 2nd and the doctor didn't really say anything. They believed it might've been related to the vaccine. They gave me a full body adjustment in hopes that would help with the issues. This was in relation to my arthritis flaring up. Its progressively getting worse, it was just a numbing pain, and now it wakes me up in the middle of the night. Cold packs and exercises for those areas and I don't really take any pain reliever because of their side effects.
This case was reported by a healthcare professional and described the occurrence of muscle pain in a 63-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). In 2009 the subject received 1st dose of FLULAVAL (.5 ml, left arm). In 2009, less than one day after vaccination with FLULAVAL, the subject experienced muscle pain and feeling terrible. The nurse reported that she had received FLULAVAL during the day three weeks prior to reporting of this event. The nurse began to feel horrible and experienced muscle pain on the same day. The nurse reported that these symptoms have continued ever since. At the time of this reporting, the nurse has scheduled a doctor's appointment for later in the week. At the time of reporting muscle pain and feeling terrible were unresolved. The healthcare professional considered muscle pain and feeling terrible were probably related to vaccination with FLULAVAL. This was one of two cases reported by this nurse; see case A0810811A for at least three subjects with unspecified adverse events. Follow up was received on 23 October 2009 via the subject. Onset date of muscle pain and feeling terrible was reported as approximately 01 September 2009. The subject also reported muscle soreness which began on 01 September 2009. The outcome was "the same". At the time of this reporting, muscle pain and feeling terrible were still unresolved. The subject was treated with ADVIL and ALEVE. The subject considered muscle pain and feeling terrible were not associated with medical history/concurrent illness, lack of efficacy, erroneous administration, or suspected transmission of an infectious agent via a medicinal product. This was one of two cases reported by this nurse; see case A0810811A for at least three subjects with unspecified adverse events.
Tiredness on 1st day.; Heart racing; chest ache; dizziness within 15 minutes; Pain at injection site within 24-48 hours.; Chills; sinus congestion; lymph nodes swelling occipital and throat; muscle ache; dry/buffy eyes; dry/buffy eyes; sore throat within 48 hrs; This is a spontaneous report from a contactable consumer or other non hcp.     A 35-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: unknown; Expiration Date: unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 15Apr2021 09:30 (at the age of 35 years) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included oxymetazoline. On 17Apr2021 07:00, the patient experienced tiredness on 1st day, heart racing, chest ache, dizziness within 15 minutes, pain at injection site within 24-48 hours, chills, sinus congestion, lymph nodes swelling occipital and throat, muscle ache, dry/buffy eyes, sore throat within 48 hrs. The patient underwent lab tests and procedures which included heart rate: racing. The clinical outcome of the events was resolving.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
On 3/13/00, the pt received her 1st IM, left deltoid dose of Havrix. On 3/22/00, 9 days later, the pt experienced swollen lymph nodes, muscle pain and a stiff neck. On 4/5/00, the pt self-treated with ibuprofen (Advil) and methyl salicylate/menthol (Ben-Gay) with "some relief". As of 5/18/00, the reporter noted that the pt had significant muscle tightness throughout her shoulders, neck and chest. She was treated with ibuprofen and physical therapy. As of 12/28/00, the outcome of the events is unknown.
I had a sore arm and weak for about a day after receiving the vaccine. I started not feeling well with a lot of mucus in my throat and a nasty cough. I went to a medical clinic, and they diagnosed me with a virus. I was given a prescription to help with my cough, but I don't think they are working.
Fever over 103, chills, bodyaches, crippling headache, extreme exhaustion , pain at injection site, tingling skin, blurred vision
Patient's right arm began to get very sore within 8 hours and it hurt for 2 days. After 2 days the soreness began to subside but a red, blotchy rash approximately 2 x 3" appeared on the lower part of the upper arm below where the shot was given. The rash was warm but did not hurt or itch. Patient was advised to use some ice to help the redness to subside and potentially use hydrocortisone 1% cream or an antihistamine cream. She was also told that the rash could worsen slightly before it starts to improve and advised to notify us again if it gets much worse. Patient had her PREVNAR shot just over 1 year ago so this PNEUMOVAX completes her series.
Patient received Moderna COVID-19 vaccine for the second dose instead of Pfizer. He received the Pfizer vaccine on 04/01/2021. Prior to administration patient was asked multiple times if he received the Moderna COVID-19 vaccine and responded, "yes." Patient was given the Moderna vaccine by the vaccinator. The vaccinator then asked the supervisor to make a new card for his first dose and after looking up the patient's record it was observed that the patient received Pfizer for his first dose. Education was provided to the patient regarding the incident and that he does not have to repeat his first dose. Patient verbalized understanding.
On 1/8 she took her 2nd dose of Pfizer vaccine around 3 PM. She went home in the evening and started sweating. She passed out. Her daughter was at home and she took her to the nearest hospital. Her BP was 60/34 and she had a temp of 100.3F on 1/8 during hospital admission. Her K was low. She received lot of fluids. She called our office on 1/10 and during the f/u she was still in the hospital. On 1/10 she has a temp of 98.4F and BP of 109/61. But she still has dizziness, nausea, anorexia and mild cough (Former smoker). COVID-19 test was done on 1/9, its negative. Dx was dehydration. Discharged from the hospital on 1/11, feels better but is tired. Will follow up with PCP on 1/16/21.
Pt recvd Td vax & devel abscess; took 2 months to heal & scar tissue has formed @ site of inject;
Ten days after first dose my injection site swelled and was red for about 24 hours.  The swelling was roughly four inches in diameter.  The area that was swelling felt dense, hot, and itchy on-and-off for 24 hours.  Then injection site still has a tiny, one inch, light red spot.  Not itchy.
4 hrs p/vax pt awoke, refused to nurse; dad held pt & mom noticed pt limp, pale, unresponsive in dads arms; when pt was aroused  had high pitched cry; seen by MD advised no more DTP;
The arm where it was vaccinated is red and hot in about 3 or 4 places.  They are still red and hot today.
17APR91 Mom called pt started vomiting following immun. Child seen in ER-vomiting listless. ER called to verify immun given.18Apr91 mom stated DX:dehydration & ear infect. Given ATB. Pt to be seen by MD for F/U
Fridge temp out of range 1-10-17. No adverse reaction. No re-vax recommended due to age.
2.5 x 1.5 inch induration on the right thigh - Hep A site. 2.0 x 1.5 inch induration on the left thigh - PREVNAR site. No sign of cellulitis/no exudate/does not fluctuate.
I contracted COVID-19 on 06/11/2022 with symptoms of sore throat, congestion, sneezing, itchy eyes, raspy voice, chest tightness, shortness of breathe, fever of 101.5 at highest point, fatigue, and cough. I was prescribed Paxlovid 06/13/2022 during a telemedicine visit. I began to feel better once I began taking the Paxlovid, but a week after I finished my doses my symptoms rebounded and I continued to test positive for 3 weeks from onset. My symptoms did not resolve until 06/30/2022. I am still experiencing lingering symptoms of a raspy voice, chest tightness, shortness of breathe, and fatigue.
Arm  hurting; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm  hurting) and VOMITING (Threw up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood sugar decreased (so she had to take two sugar pills).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VOMITING (Threw up). On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm  hurting). At the time of the report, VACCINATION SITE PAIN (Arm  hurting) outcome was unknown and VOMITING (Threw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event of vaccination site pain, a causal relationship cannot be excluded.  Based on reporter's causality of the event of vomiting, the event is assessed as unlikely related to mRNA-1273.
Reports dizziness, and  local redness within 2-3 hours of immunization 12/4/08 no syncope. No fever -  dizziness was objective - lasting over nite (12 hours) now resolved. 3.5 x 2.5 cm Lt arm tender red hardened area centered remious.
sore injection site arm after the second dose; fatigue after the second dose; headache after the second dose; muscle pain after the second dose; joint pain after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm after the second dose), FATIGUE (fatigue after the second dose), HEADACHE (headache after the second dose), MYALGIA (muscle pain after the second dose) and ARTHRALGIA (joint pain after the second dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Overweight and Diabetes. Concomitant products included PARACETAMOL (TYLENOL 8 HOUR) for an unknown indication.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION SITE PAIN (sore injection site arm after the second dose), FATIGUE (fatigue after the second dose), HEADACHE (headache after the second dose), MYALGIA (muscle pain after the second dose) and ARTHRALGIA (joint pain after the second dose). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) for Adverse event, at an unspecified dose and frequency. In 2021, VACCINATION SITE PAIN (sore injection site arm after the second dose), FATIGUE (fatigue after the second dose), HEADACHE (headache after the second dose), MYALGIA (muscle pain after the second dose) and ARTHRALGIA (joint pain after the second dose) had resolved.            This case was linked to MOD-2022-516527, MOD-2022-516539 (Patient Link).   Reporter did not allow further contact
I don't have an appetite / I force myself to eat; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (I don't have an appetite / I force myself to eat) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 026C21A and 026C21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot on 09-Dec-2021. Past adverse reactions to the above products included No adverse reaction with Flu shot.   On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2022, the patient experienced DECREASED APPETITE (I don't have an appetite / I force myself to eat). At the time of the report, DECREASED APPETITE (I don't have an appetite / I force myself to eat) outcome was unknown.            No concomitant medications were reported.  It was reported that patient had lost sense of smell & taste, before the booster. On 06 Jan 2022, it was informed that the patient still can't taste or smell however can taste honey.   No treatment medications were reported.   This case was linked to MOD-2022-442047 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jan-2022: Non significant information received On 06-Jan-2022: Follow-up received and patient demographics added , vaccination details added , Event added and it was confirmed that loss of taste and loss of smell happened prior to booster dose.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 23-JAN-2017, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster accompanied by pain. Shortly after receiving the ZOSTAVAX, the patient developed burning, itching, redness and broke out in a rash. In response to these complaints, the patient presented to a physician and was diagnosed as suffering from herpes zoster. As a result of the ZOSTAVAX, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. As a direct result of the ZOSTAVAX, the patient symptoms and diagnoses have resulted in physical limitations not present prior to using the ZOSTAVAX. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the events was considered to be not recovered. Herpes zoster and vaccination failure were considered to be disabling. Additional information has been requested.
Headache; Discomfort  / at injection site; Small swelling at injection site; Body aching (not severe); This case was reported by a nurse via call center representative and described the occurrence of headache in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th September 2020 09:00, the patient received the 1st dose of Shingrix. On 18th September 2020, less than a day after receiving Shingrix, the patient experienced headache, injection site discomfort, injection site swelling and general body pain. On an unknown date, the outcome of the headache, injection site discomfort and general body pain were recovered/resolved and the outcome of the injection site swelling was unknown.   It was unknown if the reporter considered the headache, injection site discomfort, injection site swelling and general body pain to be related to Shingrix.  Additional details were provided as follows: The reporting retired nurse was the concerned patient. The age at vaccination was not reported but it could be 70 or 71 years. In the evening, the patient developed headache, discomfort and small swelling at injection site, and body aching (not severe). The patient reported not having fever neither chills. All symptoms were gone after 48 hours. No other information was provided. Lot number and Expiry date was not available at time of reporting. The reporter consented to follow up.
On 9/30/05 parent noticed knot in left anterior thigh. On 10/01/2005 there was a 3cm area of erythema and warmth advised warm compresses and Tylenol and Motrin for Pain. Return  prn.
This initial spontaneous report was received from a Registered Nurse (RN) who wrote an online article that was posted on social media and refers to her son (age not specified). No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unspecified date, the reporter's son received GARDASIL (dose, route, and number in the series he received were not specified). The RN stated in the article that due to the restrictions of the law, her son and thousands of children like him have never been able to have their injuries acknowledged in a court of law. The injuries were not further specified. No further information was provided. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1608USA000622: